CRISPR-Cas9 enables efficient genome engineering of the strictly lytic, broad host-range staphylococcal bacteriophage K
Preprint
Abstract
Staphylococcus aureus is an important opportunistic pathogen, responsible for a range of diseases that often prove challenging to treat due to resistance to methicillin, vancomycin, and other antimicrobials. Bacteriophages present a promising alternative to target such pathogens, particularly when conventional drugs are ineffective. The antimicrobial efficacy of phage therapeutics can be further improved through genetic engineering. Among S. aureus phages, members of the Twortvirinae subfamily, characterized by their strictly lytic nature and broad host range, are considered the most promising therapeutic candidates. However, their large genome sizes make them notoriously difficult to engineer. In this study, we utilized Twortvirus K as a model to develop an efficient phage engineering platform, leveraging homologous recombination and CRISPR-Cas9-assisted counterselection. As proof of principle, this platform was utilized to construct a nanoluciferase ( nluc )-encoding reporter phage (K:: nluc ) and tested as a preliminary, bioluminescence-based approach for identifying viable Staphylococcus cells. Independent of their phage-resistance profile, 100% of tested clinical S. aureus isolates emitted bioluminescence upon K:: nluc challenge. This diagnostic assay was further adapted to complex matrices such as human whole blood and bovine raw milk, simulating S. aureus detection scenarios in bacteremia and bovine mastitis. Beyond reporter phage-based diagnostics, our engineering technology opens avenues for the design and engineering of therapeutic Twortvirinae phages to combat drug-resistant S. aureus strains.Keywords
All Related Versions
- Published version: Applied and Environmental Microbiology, 91 (9), e0201424.
This publication has 71 references indexed in Scilit:
- Genetic Engineering and Rebooting of Bacteriophages in L-Form Bacteria2023
- Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibioticsMolecular Biology Reports, 2023
- Engineering therapeutic phages for enhanced antibacterial efficacyCurrent Opinion in Virology, 2022
- Culture-independent detection systems for bloodstream infectionClinical Microbiology and Infection, 2022
- Bacteriophage-based advanced bacterial detection: Concept, mechanisms, and applicationsBiosensors and Bioelectronics, 2021
- Enhancing phage therapy through synthetic biology and genome engineeringCurrent Opinion in Biotechnology, 2021
- Methods for detection of viable foodborne pathogens: current state-of-art and future prospectsApplied Microbiology and Biotechnology, 2020
- Reprogramming Bacteriophage Host Range through Structure-Guided Design of Chimeric Receptor Binding ProteinsCell Reports, 2019
- Engineering Phage Host-Range and Suppressing Bacterial Resistance through Phage Tail Fiber MutagenesisCell, 2019
- Bacteriophage T4 Host Range is Expanded by Duplications of a Small Domain of the Tail Fiber AdhesinJournal of Molecular Biology, 1996